Reporter

Possible COVID-19 “decoy”

It might be possible to use vesicles carrying the receptor for SARS-CoV-2, the virus that causes COVID-19, to bind the virus and prevent infection.

Liver transplant donor Sam Burnett with surgical team members, from left, Lee Gordon, MD, Lea Matsuoka, MD, Sophoclis Alexopoulos, MD, Martin Montenovo, MD, Ahlie Kerr, RN, and Joseph Awad, MD.

Living liver donor program performs first transplant

The Vanderbilt Transplant Center’s newly launched living liver donor program allows relatives to donate part of their liver to their loved one, something only possible at select centers in the country.

Noninvasive treatment for refractory OCD, major depression shows promise for lifelong benefits

Four months ago, a multidisciplinary care team at Vanderbilt University Medical Center treated a patient with lifelong major depressive disorder (MDD) and obsessive compulsive disorder (OCD) — conditions that left her debilitated with intrusive thoughts, constant fear, suicidal intent and anorexia.

Study explores nicotine patch to treat late-life depression

Backed by nearly $5 million in funding, researchers from Vanderbilt University Medical Center are testing to see whether transdermal nicotine patches can improve mood, forgetfulness and attentiveness in adults over 60 with a diagnosis of depression.

x-ray of stomach

Factor involved in stomach injury response identified

Researchers at Vanderbilt University Medical Center have identified a key factor that coordinates the body’s repair response to severe injury in the stomach caused, most commonly, by infection by the bacterium Helicobacter pylori.

close up of blood vessels

Brain blood vessel response to hypoxia

The brain’s response to low oxygen — growth and remodeling of blood vessels — involves certain cell types and molecular pathways, Vanderbilt researchers have discovered.

1 168 169 170 171 172 725